MKI67 and neoplasm: Quantification of Ki67 positive tumor cells showed that SUM44 GR− tumors had a two-fold relative increase in percent positivity compared to SUM44 GR+ tumors (14% vs. 7% p < 0.0001, two-way ANOVA with Šídák post hoc test) (Figure 5I).